Plaunotol, a cytoprotective antiulcer agent, has a bactericidal effect
against Helicobacter pylori, which may result from interaction of thi
s compound with the bacterial cell membrane. The purpose of the presen
t study was to confirm that plaunotol interacts with the H. pylori mem
brane. Membrane fluidities were measured using two stearic acid spin l
abels, namely 5-doxyl-stearic acid (in which the nitroxide group is lo
cated in the upper portion of the bacterial cell membrane) and 16-doxy
l-stearic acid methyl ester (in which the nitroxide group is located d
eeper in the bacterial cell membrane), by means of electron spin reson
ance. The membrane fluidities of plaunotol-treated cells were signific
antly increased in the measurements made using the two spin labels. We
also attempted to isolate plaunotol-resistant H. pylori in vitro by t
wo different methods. To assess the level of resistance that could be
reached, H. pylori was passaged five times on an agar plate containing
subinhibitory concentrations of plaunotol or metronidazole. To measur
e the rate of development of resistance, H. pylori was grown with subi
nhibitory concentrations (0.25 x MIG) of plaunotol or metronidazole, a
nd quantitatively plated on to medium containing 4 x MIC of the compou
nds. This treatment was repeated once more. No plaunotol-resistant col
onies were selected by the two methods. H. pylori developed resistance
to metronidazole easily and at a relatively high rate. The mechanism
by which plaunotol directly fluidizes and destroys the H. pylori membr
ane might make it difficult for this organism to develop resistance to
plaunotol. It was confirmed that the bactericidal effects of plaunoto
l were also shown against Staphylococcus aureus, Streptococcus pneumon
iae, Neisseria gonorrhoeae, Moraxella catarrhalis and Haemophilus infl
uenzae. No such effect was seen against Escherichia coil and Pseudomon
as aeruginosa.